EUVIMEDEUVIMED entdecken
Crossref

Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes

Jilan A Nazeam, Ian Black, Varughese A Mulamoottil, Nabil M Selim, Riham A El Shiekh, Karema Abu-Elfotuh, Ahmed M E Hamdan, Ayah M H Gowifel, Shaimaa M Hafez, Ehsan K Mohamed, Ahmed M Atwa, Hala Mohamed El Hefnawy und 1 weitere

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Jilan A Nazeam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, October 6 University, Giza, Egypt; Complex Carbohydrate Research Center, University of Georgia, Ath…. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Polysaccharides, Abelmoschus, Neuroinflammatory Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 136 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Global healthcare systems are under tremendous strain due to the increasing prevalence of neurodegenerative disorders. Growing data suggested that overconsumption of high-fat/high-carbohydrates diet (HFHCD) is associated with enhanced incidence of metabolic alterations, neurodegeneration, and cognitive dysfunction. Functional foods have gained prominence in curbing metabolic and neurological deficits. Consequently, this study endeavored to explore effects of purified Okra seed polysaccharides (OP) (Abelmoschus esculentus (L.) Moench) against HFHCD-induced metabolic alterations and cognitive dysfunction, with elucidating underlying contributed mechanistic pathways. OP hydrolysate was analyzed using GC-MS analysis. The biological study encompassed two phases, the first phase I (model establishment phase), for 3 months, involved a control group, fed standard diet, and HFHCD group. The second phase (phase II) where HFHCD fed rats were re-divided into 3 equal subgroups, 1st subgroup received HFHCD, whereas second and third subgroups received OP, 200 or 400 mg/kg/day, respectively, for 28 days. GC-MS characterized OP as an arabinogalactouranan and revealed the monosaccharide composition as galacturonic acid: arabinose: glucose: galactose: rhamnose: xylose in ratio of 28.2: 23.3: 11.5: 4.2: 3.5: 2.0. The findings demonstrated that OP dose-dependently mitigated HFHCD-induced rise in body weights, lipid profiles, levels of blood glucose and disruption in behavioral outcomes, neurotransmitters, together with histopathological alterations in brain. Moreover, OP dose-dependently improved redox, neuroinflammatory, endoplasmic reticulum (ER) stress, autophagic and apoptotic biomarkers. OP can be regarded as promising functional food candidate to hamper HFHCD-induced metabolic alterations and cognitive deficit, via enhancing Nrf2/HO-1, AMPK/SIRT1 and PI3K/AKT/CREB axes, long with dampening of HMGB1/RAGE/TLR4, NLRP3/Caspase-1, JAK-2/STAT-3 and PERK/CHOP axes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionPolysaccharidesAbelmoschusNeuroinflammatory DiseasesAnimalsRatsMaleSeedsSignal TransductionDiet, High-Fat

Stichwörter der Autor:innen

AutophagyCognitive dysfunctionEndoplasmic reticulum stressHFHCDNeuroinflammationOkra seed polysaccharides

Substanzen

Polysaccharides

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, October 6 University, Giza, Egypt; Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA. Electronic address: jilannazeam@o6u.edu.eg.
  • Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA. Electronic address: Ianblack@ccrc.uga.edu.
  • Complex Carbohydrate Research Center, University of Georgia, Athens, GA, USA. Electronic address: Varualex@uga.edu.
  • Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza 11562, Egypt. Electronic address: nabil.selim@pharma.cu.edu.eg.
  • Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Giza 11562, Egypt. Electronic address: riham.adel@pharma.cu.edu.eg.
  • Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo 11884, Egypt; Al-Ayen Iraqi University, Thi-Qar 64001, Iraq. Electronic address: Karimasoliman.pharmg@azhar.edu.eg.

Zitieren

APA

Nazeam, J. A., Black, I., Mulamoottil, V. A., Selim, N. M., El Shiekh, R. A., Abu-Elfotuh, K., Hamdan, A. M. E., Gowifel, A. M. H., Hafez, S. M., Mohamed, E. K., Atwa, A. M., El Hefnawy, H. M., & Azadi, P. (2025). Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114110

Vancouver

Nazeam JA, Black I, Mulamoottil VA, Selim NM, El Shiekh RA, Abu-Elfotuh K, et al. Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114110

BibTeX
@article{Nazeam2025,
  author = {Nazeam, Jilan A and Black, Ian and Mulamoottil, Varughese A and Selim, Nabil M and El Shiekh, Riham A and Abu-Elfotuh, Karema and Hamdan, Ahmed M E and Gowifel, Ayah M H and Hafez, Shaimaa M and Mohamed, Ehsan K and Atwa, Ahmed M and El Hefnawy, Hala Mohamed and Azadi, Parastoo},
  title = {Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114110}
}
Kostenlos starten →